Bacterin International Holdings Inc has secured $4 million more in funding from OrbiMed and will be issuing 1.5 million shares of common stock to the investment firm as part of the deal, a statement about the funding said.
Breaking News
Igenica Inc, the biopharmaceutical firm dedicated to developing antibodies and antibody-drug conjugates to treat the Big C, obtained $14 million in its Series C extension round.
TigerText, a real-time messaging provider for the enterprise, has closed its Series B round led by Shasta Ventures with $21 million. New and existing investors also participated in the financing.
Subscribe to VCpost newsletter
Most Popular
- Former CEO Shoots Himself to Commit Suicide After Receiving $25 Million Record-Breaking Fine for Fraud at Steinhoff
- Xi Jinping Warns Dutch PM That 'No Force' Can Stop China's Technological Advancement Amid Export Restrictions
- Disney Investor Nelson Peltz Criticizes the Company’s 'Woke' Strategy, Questioning 'Black Panther' and 'The Marvels' Films
- Major AI Companies Unite to Create the World's First Artificial Superintelligence Alliance Worth $7.6 Billion
- Social Security Benefits to Increase for Some Seniors After Addressing Overpayment Issues
- North Korea Refuses Peace Talk With Japan Unless They Confront Their 'Brutal' History; Business Relations at Risk
- Citigroup to Complete Sweeping Overhaul This Week After Laying Off 5,000 Employees
- Businessman Brutally Murdered Allegedly by 4 of His Workers Who Swung an Axe Into His Head